Figure 6.
The effect of lazertinib and amivantamab on migration and proliferation of patient’s lung adenocarcinoma cells. (A) Scratch assay shows lazertinib inhibits migration ability of lung adenocarcinoma cells better than amivantamab; (B) Colony-forming unit assays shows lazertinib inhibits lung adenocarcinoma cell proliferation ability more than amivantamab. *p < 01, ***p < 0.001.